| Jeremy S Bordeaux, MD MPH | |
|
281 Lincoln Street, Umass Dermatology Hahnemann Campus, Worcester, MA 01605 | |
| (508) 334-5971 | |
| Not Available |
| Full Name | Jeremy S Bordeaux |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 26 Years |
| Location | 281 Lincoln Street, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043242589 | NPI | - | NPPES |
| 2771522 | Medicaid | OH | |
| 000000524092 | Other | OH | ANTHEM |
| P00406576 | Other | OH | RAILROAD MEDICARE |
| 000000221131 | Other | OH | UNISON |
| 750496 | Other | OH | BUCKEYE |
| 5569102 | Other | OH | AETNA |
| 414951 | Other | OH | WELLCARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Hospitals Medical Group Inc | 4789682493 | 1466 |
News Archive
Aerocrine AB (STO:AEROB) today announced that Health Canada's Therapeutic Products Directorate has approved Aerocrine's NIOX MINO® technology for use in treating asthma. Canada's National Health Service may now begin using the NIOX MINO, a medical device that provides a measure of the degree of inflammation in the airways in a single breath.
A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease, sporadic inclusion body myositis, and in elderly patients with sarcopenia according to research published ahead of print in the journal Molecular and Cellular Biology.
Arizona Oncology is proud to be a part of the larger network that just completed a recently conducted study by US Oncology and Aetna that finds evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes.
Times have changed. Within the last ten years, the primary reason that children have had surgery to remove their tonsils and adenoids is not because of infection. Instead, up to 90 percent of the adenotonsillectomy surgeries are to correct obstructive sleep apnea (OSA).
Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart - a breakthrough that may open up new cardiac pacing options for children and adults.
› Verified 1 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
Aerocrine AB (STO:AEROB) today announced that Health Canada's Therapeutic Products Directorate has approved Aerocrine's NIOX MINO® technology for use in treating asthma. Canada's National Health Service may now begin using the NIOX MINO, a medical device that provides a measure of the degree of inflammation in the airways in a single breath.
A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease, sporadic inclusion body myositis, and in elderly patients with sarcopenia according to research published ahead of print in the journal Molecular and Cellular Biology.
Arizona Oncology is proud to be a part of the larger network that just completed a recently conducted study by US Oncology and Aetna that finds evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes.
Times have changed. Within the last ten years, the primary reason that children have had surgery to remove their tonsils and adenoids is not because of infection. Instead, up to 90 percent of the adenotonsillectomy surgeries are to correct obstructive sleep apnea (OSA).
Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart - a breakthrough that may open up new cardiac pacing options for children and adults.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy S Bordeaux, MD MPH 24701 Euclid Ave, 3rd Floor, Euclid, OH 44117-1714 Ph: () - | Jeremy S Bordeaux, MD MPH 281 Lincoln Street, Umass Dermatology Hahnemann Campus, Worcester, MA 01605 Ph: (508) 334-5971 |
News Archive
Aerocrine AB (STO:AEROB) today announced that Health Canada's Therapeutic Products Directorate has approved Aerocrine's NIOX MINO® technology for use in treating asthma. Canada's National Health Service may now begin using the NIOX MINO, a medical device that provides a measure of the degree of inflammation in the airways in a single breath.
A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease, sporadic inclusion body myositis, and in elderly patients with sarcopenia according to research published ahead of print in the journal Molecular and Cellular Biology.
Arizona Oncology is proud to be a part of the larger network that just completed a recently conducted study by US Oncology and Aetna that finds evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes.
Times have changed. Within the last ten years, the primary reason that children have had surgery to remove their tonsils and adenoids is not because of infection. Instead, up to 90 percent of the adenotonsillectomy surgeries are to correct obstructive sleep apnea (OSA).
Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart - a breakthrough that may open up new cardiac pacing options for children and adults.
› Verified 1 days ago
Mariko Yasuda, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Dermatology Residency, Worcester, MA 01605 Phone: 508-334-5971 | |
Dr. Ryan M Svoboda, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 | |
Kaitlyn Yim, MD Dermatology Medicare: Medicare Enrolled Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 | |
Zoe Brown-joel, MD Dermatology Medicare: Medicare Enrolled Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 | |
John E Harris, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 | |
Sarah K Whitley, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 |